Siam Life Science is a Thailand-based biotechnology company at the forefront of the development of cell technologies and cell processing platforms.  Our core strengths are in the establishment of cellular solutions involving primary human liver cell and human liver-derived immortalized cell lines of Asian origin for research, drug development and potentially for the development and commercialization of bio-artificial liver devices.

Cell technologies are becoming increasingly important in human healthcare and drug development processes.  Cellular platforms are already widely used in pharmaceutical research and preclinical drug and toxicity testing, most of which involve liver cell based systems ... More >>

 
 
Primary Heptocytes
Primary hepatocytes are human liver cells obtained from surplus tissue that are derived from liver cancer resections ... More >>
 
Immortalised Heptocytes
Siam Life Science had cooperated with the Walter Reed Army Institute of Research and co-developed an immortalized ... More >>
           
 
Preclinical Drug Testing
Siam Life Science aims to leverage upon its expertise in hepatology and toxicology to offer services ... More >>
 
Contract R&D
Siam Life Science aims to leverage upon its expertise in hepatology and toxicology to offer services ... More >>